Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2018

13.02.2018 | Original Article

Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing

verfasst von: Zheng Yu, Rongchang Wang, Fan Chen, Jianru Wang, Xiaohui Huang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Alpha-fetal protein (AFP) is an important conventional clinical diagnostic indicator of hepatocellular carcinoma (HCC). However, the utilization of AFP alone might yield deceptive results due to its limited sensitivity and accuracy.

Aims

Our study was designed to investigate latent diagnostic biomarkers that could function as auxiliary clinical indicators of HCC and enhance the accuracy of joint diagnosis with AFP.

Methods

We analyzed gene expression profiles and clinical data from HCC patients in The Cancer Genome Atlas database. Differentially expressed genes were identified, and a gene set enrichment analysis was conducted to uncover their biological functions and molecular processes. A weighted correlation network analysis and a protein–protein interaction analysis were performed to detect AFP-related biomarkers. The diagnostic performance of these biomarkers was verified using datasets from the GEO database. A diagnostic nomogram was established using the expression levels of potential biomarkers. Quantitative real-time PCR was performed using tissues from 16 HCC patients to validate the results.

Results

Five AFP-related diagnostic biomarkers, CDT1, MCM7, NUDT1, CENPM, and HDAC11, were discovered. The diagnostic performance of these biomarkers and the nomogram were demonstrated to be excellent according to receiver operating characteristic curves. CDT1, MCM7, and NUDT1 were shown to be up-regulated in HCC tissues through quantitative real-time PCR.

Conclusions

We discovered five diagnostic biomarkers and established a nomogram as a complement to AFP in the diagnosis of HCC. Our results provide a more accurate diagnostic plan for HCC patients based on next-generation sequencing compared with AFP alone.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2016;2:16018.CrossRefPubMed Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2016;2:16018.CrossRefPubMed
2.
Zurück zum Zitat Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–687.CrossRefPubMed Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–687.CrossRefPubMed
3.
Zurück zum Zitat Chacko S, Samanta S. Hepatocellular carcinoma: a life-threatening disease. Biomed Pharmacother. 2016;84:1679–1688.CrossRefPubMed Chacko S, Samanta S. Hepatocellular carcinoma: a life-threatening disease. Biomed Pharmacother. 2016;84:1679–1688.CrossRefPubMed
4.
Zurück zum Zitat Barletta E, Tinessa V, Daniele B. Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography. Recent Prog Med. 2005;96:295–299. (quiz 328). Barletta E, Tinessa V, Daniele B. Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography. Recent Prog Med. 2005;96:295–299. (quiz 328).
5.
Zurück zum Zitat Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23:5282–5294.CrossRefPubMedPubMedCentral Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23:5282–5294.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ohori Tatsuo G, Riu Hamada M, Gondo T, Hamada R. Nomogram as predictive model in clinical practice. Gan To Kagaku Ryoho. 2009;36:901–906. Ohori Tatsuo G, Riu Hamada M, Gondo T, Hamada R. Nomogram as predictive model in clinical practice. Gan To Kagaku Ryoho. 2009;36:901–906.
7.
Zurück zum Zitat Rosok O, Sioud M. Discovery of differentially expressed genes: technical considerations. Methods Mol Biol. 2007;360:115–129.PubMed Rosok O, Sioud M. Discovery of differentially expressed genes: technical considerations. Methods Mol Biol. 2007;360:115–129.PubMed
8.
Zurück zum Zitat Vietor I, Huber LA. In search of differentially expressed genes and proteins. Biochem Biophys Acta. 1997;1359:187–199.CrossRefPubMed Vietor I, Huber LA. In search of differentially expressed genes and proteins. Biochem Biophys Acta. 1997;1359:187–199.CrossRefPubMed
9.
Zurück zum Zitat Hardwick SA, Deveson IW, Mercer TR. Reference standards for next-generation sequencing. Nat Rev Genet. 2017;18:473–484.CrossRefPubMed Hardwick SA, Deveson IW, Mercer TR. Reference standards for next-generation sequencing. Nat Rev Genet. 2017;18:473–484.CrossRefPubMed
10.
12.
Zurück zum Zitat Tomczak K, Czerwinska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol. 2015;19:A68–A77. Tomczak K, Czerwinska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol. 2015;19:A68–A77.
13.
14.
Zurück zum Zitat Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–15550.CrossRefPubMedPubMedCentral Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–15550.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267–273.CrossRefPubMed Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267–273.CrossRefPubMed
16.
Zurück zum Zitat Gene Ontology C. The Gene Ontology (GO) project in 2006. Nucleic Acids Res. 2006;34:D322–D326.CrossRef Gene Ontology C. The Gene Ontology (GO) project in 2006. Nucleic Acids Res. 2006;34:D322–D326.CrossRef
17.
Zurück zum Zitat Du J, Yuan Z, Ma Z, Song J, Xie X, Chen Y. KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model. Mol BioSyst. 2014;10:2441–2447.CrossRefPubMed Du J, Yuan Z, Ma Z, Song J, Xie X, Chen Y. KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model. Mol BioSyst. 2014;10:2441–2447.CrossRefPubMed
19.
20.
Zurück zum Zitat Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362–D368.CrossRefPubMed Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362–D368.CrossRefPubMed
21.
Zurück zum Zitat Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364–1370.CrossRefPubMed Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364–1370.CrossRefPubMed
22.
Zurück zum Zitat Xu WF, Fei YM, Zhou JK, et al. Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expression in primary hepatic carcinoma. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011;25:286–288.PubMed Xu WF, Fei YM, Zhou JK, et al. Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expression in primary hepatic carcinoma. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011;25:286–288.PubMed
23.
Zurück zum Zitat Xu RH, Wei W, Krawczyk M, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat Mater. 2017;16:1155–1161.CrossRefPubMed Xu RH, Wei W, Krawczyk M, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat Mater. 2017;16:1155–1161.CrossRefPubMed
24.
Zurück zum Zitat Matsuzaki J, Suzuki H. Circulating microRNAs as potential biomarkers to detect transformation of Barrett’s oesophagus to oesophageal adenocarcinoma. BMJ Open Gastroenterol. 2017;4:e000160.CrossRefPubMedPubMedCentral Matsuzaki J, Suzuki H. Circulating microRNAs as potential biomarkers to detect transformation of Barrett’s oesophagus to oesophageal adenocarcinoma. BMJ Open Gastroenterol. 2017;4:e000160.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Caillat C, Perrakis A. Cdt1 and geminin in DNA replication initiation. Sub Cell Biochem. 2012;62:71–87.CrossRef Caillat C, Perrakis A. Cdt1 and geminin in DNA replication initiation. Sub Cell Biochem. 2012;62:71–87.CrossRef
27.
Zurück zum Zitat Karavias D, Maroulis I, Papadaki H, et al. Overexpression of CDT1 Is a predictor of poor survival in patients with hepatocellular carcinoma. J Gastroint Surg. 2016;20:568–579.CrossRef Karavias D, Maroulis I, Papadaki H, et al. Overexpression of CDT1 Is a predictor of poor survival in patients with hepatocellular carcinoma. J Gastroint Surg. 2016;20:568–579.CrossRef
29.
Zurück zum Zitat Winther TL, Torp SH. MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas. J Neurooncol. 2017;131:575–583.CrossRefPubMed Winther TL, Torp SH. MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas. J Neurooncol. 2017;131:575–583.CrossRefPubMed
30.
Zurück zum Zitat Qu K, Wang Z, Fan H, et al. MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. Cell Death Dis. 2017;8:e2603.CrossRefPubMedPubMedCentral Qu K, Wang Z, Fan H, et al. MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. Cell Death Dis. 2017;8:e2603.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Chen J, Sahakian E, Powers J, et al. Functional analysis of histone deacetylase 11 (HDAC11). Methods Mol Biol. 2016;1436:147–165.CrossRefPubMed Chen J, Sahakian E, Powers J, et al. Functional analysis of histone deacetylase 11 (HDAC11). Methods Mol Biol. 2016;1436:147–165.CrossRefPubMed
32.
Zurück zum Zitat Sahakian E, Powers JJ, Chen J, et al. Histone deacetylase 11: a novel epigenetic regulator of myeloid derived suppressor cell expansion and function. Mol Immunol. 2015;63:579–585.CrossRefPubMed Sahakian E, Powers JJ, Chen J, et al. Histone deacetylase 11: a novel epigenetic regulator of myeloid derived suppressor cell expansion and function. Mol Immunol. 2015;63:579–585.CrossRefPubMed
Metadaten
Titel
Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing
verfasst von
Zheng Yu
Rongchang Wang
Fan Chen
Jianru Wang
Xiaohui Huang
Publikationsdatum
13.02.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-4961-3

Weitere Artikel der Ausgabe 4/2018

Digestive Diseases and Sciences 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.